Company
ChinaOP NanoPharma Co., Ltd. Yunlin Plant, China – FDA Inspections
Inspection records and compliance data for OP NanoPharma Co., Ltd. Yunlin Plant. 1 FDA inspection on record, 1 Form 483, last inspected July 25, 2023.
Company Profile
This profile covers OP NanoPharma Co., Ltd. Yunlin Plant based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected July 25, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 25, 2023 | Not classified | Human Drugs | 1211350 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Viwit Pharmaceutical Co., Ltd.
Hainan Simcere Pharmaceutical Co., Ltd.
Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road)
Simcere Pharmaceutical Co., Ltd.
2Y-Biopharma, Ltd.
Fosun Pharma (Xuzhou) Co., Ltd.
Bostal Drug Delivery Co., Ltd.
Zhejiang Yongtai Pharmaceutical Co. Ltd
Novast Laboratories Ltd.
Company Information
Name
OP NanoPharma Co., Ltd. Yunlin Plant
FEI Number
3023553777
Address
China
Country
China
ID: 4495840b-1be4-4fe7-a5c6-f0c0df52babd